104
Participants
Start Date
February 28, 2014
Primary Completion Date
January 31, 2018
Study Completion Date
January 31, 2018
Reparixin
Solution for intravenous (IV) infusion; 2.772 mg/kg body weight/hour administered at 0.25 mL/kg/hour
Placebo
Physiologic solution administered at 0.25 mL/kg/hour
Thomas E. Starzl Transplantation Institute University of Pittsburgh Medical Center, Pittsburgh
Medical University of South Carolina, Charleston
The University of Cincinnati Medical Center, Cincinnati
Schulze Diabetes Institute University of Minnesota Medical School, Minneapolis
The University of Chicago Medical Center, Chicago
Baylor University Medical Center, Dallas
University of California. Department of Surgery, Division of Transplantation, San Francisco
Dartmouth-Hitchcock Medical Center, Lebanon
University of Alberta, Clinical Islet Transplant Program, Edmonton
Dompé Farmaceutici S.p.A
INDUSTRY